Format

Send to

Choose Destination
Palliat Med. 2019 Jan;33(1):74-81. doi: 10.1177/0269216318801754. Epub 2018 Oct 1.

Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain.

Author information

1
1 Deakin Health Economics, Centre for Population Health Research and School of Health and Social Development, Deakin University, Burwood, VIC, Australia.
2
2 Palliative and Supportive Services, Flinders University, Adelaide, SA, Australia.
3
3 University of York, York, UK.
4
4 School of Medicine, Flinders University, Adelaide, SA, Australia.
5
5 Repatriation General Hospital, Daw Park and School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
6
6 Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.
7
7 Department of Palliative and Supportive Care, Mater Health Services, Mater Research, University of Queensland, Brisbane, QLD, Australia.
8
8 Liverpool Hospital, South West Sydney Local Health District and University of Technology Sydney, Ultimo, NSW, Australia.
9
9 Swinburne University of Technology, Melbourne, VIC, Australia.
10
10 Australian Health Services Research Institute, University of Wollongong, Wollongong, NSW, Australia.

KEYWORDS:

Economics; health status; neoplasms; palliative care; palliative medicine; patient outcome assessment; quality of life; symptoms

PMID:
30269638
DOI:
10.1177/0269216318801754

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center